Latest & greatest articles for insulin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insulin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insulin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insulin

81. Efficacy and safety profile of liraglutide combination with premixed insulin versus premixed insulin alone in overweight Type 2 Diabetes Mellitus: a systematic review and meta-analysis of randomised controlled trials

Efficacy and safety profile of liraglutide combination with premixed insulin versus premixed insulin alone in overweight Type 2 Diabetes Mellitus: a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO

82. Efficacy and safety profile of liraglutide combination with insulin intensive therapy versus insulin intensive therapy in Type 2 Diabetes Mellitus: a systematic review and meta-analysis of randomised controlled trials

Efficacy and safety profile of liraglutide combination with insulin intensive therapy versus insulin intensive therapy in Type 2 Diabetes Mellitus: a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO

83. Efficacy and safety of Glargine insulin versus NPH insulin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Efficacy and safety of Glargine insulin versus NPH insulin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

84. The link between branch chain amino acids and diabetes, insulin resistance and obesity

The link between branch chain amino acids and diabetes, insulin resistance and obesity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

85. Effect of ascorbic acid supplementation on glycemic control and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis

Effect of ascorbic acid supplementation on glycemic control and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

86. Effect of acute consumption of resistant starch on appetite, post-prandial glucose and insulin, in healthy subjects: a systematic review and meta-analysis of clinical trials

Effect of acute consumption of resistant starch on appetite, post-prandial glucose and insulin, in healthy subjects: a systematic review and meta-analysis of clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

87. Decreasing insulin requirements during the third trimester amongst women with insulin dependent gestational and pregestational diabetes and its association to maternal-fetal outcomes: a systematic review

Decreasing insulin requirements during the third trimester amongst women with insulin dependent gestational and pregestational diabetes and its association to maternal-fetal outcomes: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

88. Comparison between sodium-glucose co-transporter inhibitors of high dose and low dose, and with placebo in contemporary insulin-treated type-1 diabetes patients: a systematic review and meta-analysis of randomised controlled trials

Comparison between sodium-glucose co-transporter inhibitors of high dose and low dose, and with placebo in contemporary insulin-treated type-1 diabetes patients: a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

89. Glycemic control outcomes of manual and computerized insulin titration protocols: a systematic review protocol

Glycemic control outcomes of manual and computerized insulin titration protocols: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

90. Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans. Full Text available with Trip Pro

Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans. The gut microbiome is a source of inflammatory factors such as lipopolysaccharide (LPS; endotoxin) that influence metabolic homeostasis. Rifaximin is a well-tolerated antibiotic that may reduce LPS.We sought to develop a method to accurately assess postprandial endotoxemia and to determine whether rifaximin treatment improves metabolic homeostasis in obese humans with metabolic syndrome.Plasma LPS, adipose (...) inflammation, glucose and lipid metabolism, and insulin sensitivity were evaluated in a clinical research setting.Twelve obese human research participants with prediabetes or three features of metabolic syndrome participated.The research participants were randomized to placebo control or rifaximin soluble solid dispersion (80 mg/d) treatment groups and treated for 12 weeks.We evaluated changes in insulin sensitivity with a euglycemic clamp; changes in lipid and glucose metabolism with oral lipid

2019 Journal of the Endocrine Society Controlled trial quality: uncertain

91. A systematic review of insulin dosing strategies used for dietary fat and a combination of dietary fat and protein in Type 1 Diabetes

A systematic review of insulin dosing strategies used for dietary fat and a combination of dietary fat and protein in Type 1 Diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

92. Serum adiponectin, leptin, resistin and insulin resistance levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis

Serum adiponectin, leptin, resistin and insulin resistance levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

93. Meta-analysis of clinical trials examining initial titration of basal insulin on a background of oral glucose-lowering agents in patients with type 2 diabetes

Meta-analysis of clinical trials examining initial titration of basal insulin on a background of oral glucose-lowering agents in patients with type 2 diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

94. Oral bovine colostrum supplementation and levels of insulin-like growth factor 1 in human adults: systematic review and meta-analysis of randomised controlled trials

Oral bovine colostrum supplementation and levels of insulin-like growth factor 1 in human adults: systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

95. A systematic and meta-analysis of the chain of insulin, C-peptide and glucose levels with improvement in cognition in the elderly with physical activity

A systematic and meta-analysis of the chain of insulin, C-peptide and glucose levels with improvement in cognition in the elderly with physical activity Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

96. The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with non-alcoholic fatty liver disease: a systematic review

The effect of low glycemic index and glycemic load diets on hepatic fat mass, insulin resistance, and blood lipid panels in individuals with non-alcoholic fatty liver disease: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

97. Comparative efficacy and safety of metformin, glyburide and insulin in treating gestational diabetes mellitus: a meta-analysis

Comparative efficacy and safety of metformin, glyburide and insulin in treating gestational diabetes mellitus: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

98. Dietary inflammatory index, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: a systematic review and meta-analysis

Dietary inflammatory index, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

99. Dietary antioxidant capacity (TAC), general and central obesity indices, blood pressure, fasting blood sugar, biomarkers of insulin resistance and inflammation among adults

Dietary antioxidant capacity (TAC), general and central obesity indices, blood pressure, fasting blood sugar, biomarkers of insulin resistance and inflammation among adults Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

100. Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: findings from an updated systematic review and meta-analysis

Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: findings from an updated systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO